#clinical trials

Health

AstraZeneca's Tozorakimab Shows Promising Results for COPD in Phase 3 Trials

By Editor • September 8, 2026 • 1 min read

AstraZeneca's experimental drug tozorakimab reduces COPD flare-ups by 30% in late-stage trials, offering hope for millions of patients.

By Editor • August 19, 2026 • 1 min read

The deaths in Chinese clinical trials have sparked concerns about the oversight and safety of experimental medicine in the country.

By Editor • August 19, 2026 • 2 min read

Clinical trial participation offers hope for patients, but many face significant barriers in finding and enrolling in studies.